A new type of non-opioid painkiller, aimed at treating short-term pain in adults, has been approved by the US Food and Drug ...
The Food and Drug Administration approved a new type of nonopioid painkiller, Journaxv, or suzetrigine, drugmaker Vertex ...
The FDA granted approval for Journavx after clinical trials demonstrated its effectiveness in post-surgical pain relief ...
New research suggests that Ozempic and similar weight loss medications have the potential to be as big a game changer in ...
The kappa opioid receptor (KOR) and the endogenous peptide-ligand dynorphin ... in modulating dopaminergic neurotransmission in reward circuitry and the influence of dopamine in the transduction and ...
February is observed as American Heart Month, a period dedicated to raising awareness about heart health. The first American Heart ...
Federal officials on Thursday approved a new type of pain drug designed to eliminate the risks of addiction and overdose ...
On Wednesday, the U.S. Food and Drug Administration approved a new pain management drug which could change the way healthcare providers address pain management.